BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15953962)

  • 1. Developmental toxicity testing from animal towards embryonic stem cells.
    Pellizzer C; Bremer S; Hartung T
    ALTEX; 2005; 22(2):47-57. PubMed ID: 15953962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenge of reproductive and developmental toxicology under REACH.
    Scialli AR
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):244-50. PubMed ID: 18490093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy'': stem cells and cell-cell communication as fundamental targets in assessing the potential toxicity of chemicals.
    Trosko JE
    Hum Exp Toxicol; 2010 Jan; 29(1):21-9. PubMed ID: 20061464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotoxicity of active compounds--establishment of hESC-lines and proteomics technologies for human embryo- and neurotoxicity screening and biomarker identification.
    Klemm M; Schrattenholz A
    ALTEX; 2004; 21 Suppl 3():41-8. PubMed ID: 15057407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors to consider in the use of stem cells for pharmaceutic drug development and for chemical safety assessment.
    Trosko JE; Chang CC
    Toxicology; 2010 Mar; 270(1):18-34. PubMed ID: 19948204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strengths and limitations of using repeat-dose toxicity studies to predict effects on fertility.
    Dent MP
    Regul Toxicol Pharmacol; 2007 Aug; 48(3):241-58. PubMed ID: 17512650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The embryonic stem cell test combined with toxicogenomics as an alternative testing model for the assessment of developmental toxicity.
    van Dartel DA; Piersma AH
    Reprod Toxicol; 2011 Sep; 32(2):235-44. PubMed ID: 21575713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in improving the embryonic stem cell test (EST): an overview.
    Buesen R; Visan A; Genschow E; Slawik B; Spielmann H; Seiler A
    ALTEX; 2004; 21(1):15-22. PubMed ID: 14976585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation.
    Höfer T; Gerner I; Gundert-Remy U; Liebsch M; Schulte A; Spielmann H; Vogel R; Wettig K
    Arch Toxicol; 2004 Oct; 78(10):549-64. PubMed ID: 15170526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Improving the embryonic stem cell test (EST) by establishing molecular endpoints of tissue specific development using murine embryonic stem cells (D3 cells)].
    Seiler A; Visan A; Pohl I; Genschow E; Buesen R; Spielmann H
    ALTEX; 2002; 19 Suppl 1():55-63. PubMed ID: 12096331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative methods for developmental toxicity testing.
    Piersma AH
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):427-31. PubMed ID: 16635099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges of using pluripotent stem cells for safety assessments of substances.
    Vojnits K; Bremer S
    Toxicology; 2010 Mar; 270(1):10-7. PubMed ID: 20004228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statement of the scientific validity of the embryonic stem cell test (EST) -- an in Vitro test for embryotoxicity.
    Balls M; Hellsten E
    Altern Lab Anim; 2002; 30(3):265-8. PubMed ID: 12166399
    [No Abstract]   [Full Text] [Related]  

  • 16. The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy.
    Leist M; Bremer S; Brundin P; Hescheler J; Kirkeby A; Krause KH; Poerzgen P; Puceat M; Schmidt M; Schrattenholz A; Zak NB; Hentze H
    ALTEX; 2008; 25(3):163-90. PubMed ID: 18841314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative test methods in inhalation toxicology: challenges and opportunities.
    Costa DL
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):105-9. PubMed ID: 18486462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicology in the 21st century--working our way towards a visionary reality.
    Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
    Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use and application of stem cells in toxicology.
    Davila JC; Cezar GG; Thiede M; Strom S; Miki T; Trosko J
    Toxicol Sci; 2004 Jun; 79(2):214-23. PubMed ID: 15014205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative methods in toxicology tests: in vitro toxicity.
    Cinelli S; Falezza A; Meli C; Ciliutti P; Vericat JA
    Cytotechnology; 1991; 5 Suppl 1():51-4. PubMed ID: 1367120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.